肩峰下局部麻醉药不干扰关节镜下肩袖修复术后的肩袖愈合
本研究为队列研究(证据等级3),对118例关节镜下肩袖修复术后患者随访至少1年,比较持续肩峰下罗哌卡因输注组(33例)、患者自控肩峰下罗哌卡因输注组(30例)与其他镇痛方式组(55例)。结果显示三组在疼痛VAS、满意度VAS、ASES评分、Constant评分、愈合率、GFDI变化及等速肌力测试变化上均无显著差异。作者认为肩峰下罗哌卡因的肌毒性可能是可逆的或不足以干扰肌腱愈合和功能。
要点
- 三组术后疼痛VAS、满意度VAS、ASES评分及Constant评分均无显著差异。
- 三组愈合率、GFDI变化及等速肌力测试变化均无显著差异。
- 肩峰下罗哌卡因输注未对肩袖愈合和功能产生不良影响。
核心结论
- 当前数据提示,经镇痛泵给药的肩峰下罗哌卡因的肌毒性可能是可逆的,或不足以严重到干扰肌腱愈合和导致肌肉退变,因此可能不影响术后功能。
研究设计与样本
- 队列研究,证据等级3;延续作者3项已发表前瞻性研究的随访,共纳入118例关节镜下肩袖修复术后至少1年返回评估的患者。
- 分为3组:持续肩峰下罗哌卡因输注组(组1,n=33)、患者自控肩峰下罗哌卡因输注组(组2,n=30)、其他镇痛方式组(静脉患者自控镇痛和/或肌间沟阻滞;组3,n=55)。
主要发现
- 疼痛VAS:组1为1.1±2.3,组2为1.3±1.9,组3为0.9±1.7(P=.88);满意度VAS:组1为8.3±2.4,组2为8.7±1.5,组3为8.0±2.1(P=.64)。
- ASES评分:组1为79.5±10.5,组2为81.1±6.9,组3为75.7±7.6(P=.34);Constant评分:组1为81.8±8.7,组2为77.6±9.3,组3为78.2±8.4(P=.31)。
- 愈合率:组1为72.7%,组2为73.3%,组3为70.9%(P=.83);GFDI变化:组1为0.45,组2为0.62,组3为0.41(P=.79)。
- 等速肌力测试:外展组1为113.0%、组2为121.5%、组3为120.1%(P=.73);外旋组1为112.1%、组2为121.6%、组3为111.7%(P=.71);内旋组1为118.2%、组2为118.0%、组3为118.1%(P=.95)。
- 将组1+2与组3重新分析,功能评分、愈合率、GFDI变化及等速肌力测试变化均无显著差异(P>.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Subacromial pain pumps are used for analgesia after arthroscopic rotator cuff surgery. However, there is controversy about myotoxic or tendinotoxic effects of local anesthetics. HYPOTHESIS: Ropivacaine administered via a subacromial pain pump would have no adverse effect on rotator cuff tendon healing, fatty degeneration, strength, or functional outcomes after arthroscopic repair. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: This study continues follow-up of patients enrolled in the authors' 3 published prospective studies regarding pain control after arthroscopic rotator cuff repair. In total, 118 patients who underwent rotator cuff repair and returned for evaluation at least 1 year postoperatively were divided into 3 groups: patients who received continuous subacromial ropivacaine infusion (group 1, n = 33), those who received patient-controlled subacromial ropivacaine infusion (group 2, n = 30), and those who received other pain control modalities (intravenous patient-controlled analgesia and/or interscalene block; group 3, n = 55). At least 1 year postoperatively, tendon healing and changes in global fatty degeneration index (GFDI) were estimated through computed tomographic arthrography, magnetic resonance imaging, or ultrasonography. Changes in isokinetic muscle performance test (IMPT) were calculated and functional outcomes evaluated, including visual analog scales (VASs) for pain and satisfaction, American Shoulder and Elbow Surgeons score, and Constant score. RESULTS: At final follow-up, there were no differences in pain VAS (group 1, 1.1 ± 2.3; group 2, 1.3 ± 1.9; group 3, 0.9 ± 1.7; P = .88), satisfaction VAS (group 1, 8.3 ± 2.4; group 2, 8.7 ± 1.5; group 3, 8.0 ± 2.1; P = .64), American Shoulder and Elbow Surgeons score (group 1, 79.5 ± 10.5; group 2, 81.1 ± 6.9; group 3, 75.7 ± 7.6; P = .34), or Constant score (group 1, 81.8 ± 8.7; group 2, 77.6 ± 9.3; group 3, 78.2 ± 8.4; P = .31). Among the 3 groups, there were no significant differences in healing rates (group 1, 72.7%; group 2, 73.3%; group 3, 70.9%; P = .83) and no differences in changes of GFDI (group 1, 0.45; group 2, 0.62; group 3, 0.41; P = .79), and IMPT (abduction: group 1, 113.0%; group 2, 121.5%; group 3, 120.1%; P = .73; external rotation: group 1, 112.1%; group 2, 121.6%; group 3, 111.7%; P = .71; internal rotation: group 1, 118.2%; group 2, 118.0%; group 3, 118.1%; P = .95). When data were reanalyzed with 2 groups (group 1 + 2 vs group 3), there were no significant differences in functional scores, healing rates, or changes in GFDI and IMPT ( P > .05). CONCLUSION: Current data suggest that myotoxicity of subacromial ropivacaine administered via pain pump may be reversible or may not be so severe as to interfere with tendon healing and cause muscle degeneration and thus may not affect postoperative function.
引用
- Rhee SM, Chung NY, Jeong HJ, et al. Subacromial Local Anesthetics Do Not Interfere With Rotator Cuff Healing After Arthroscopic Repair. Am J Sports Med. 2018. PMID: 29470095. doi:10.1177/0363546517753827
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。